4 April 2018

Circulating tumor DNA in esophageal and rectal cancer patients undergoing chemoradiation therapy

Hans de Wilt and  Bastiaan Klarenbeek, theme Tumors of the digestive tract, received a research grant of 80.000 euro from the 'Bergh in het Zadel' foundation to study circulating tumor DNA in their patients. Both surgeons are involved in the multimodality treatment of rectal and esophageal cancer patients and are interested in these 'liquid biopsies' during and after treatment. In close collaboration with Prof. Ligtenberg from the department of genetics, they will study circulating tumor DNA before the start of chemoradiation of these patients and compare this during and after treatment. The results might give insight in the response of the tumor on chemoradiation therapy, but also might reflect prognosis of patients after following surgical treatment.

Related news items


Frank Walboomers 25-years work anniversary at Radboudumc

17 September 2020

Frank Walboomers, associate professor at the research group Regenerative Biomaterials at the Dept. of Dentistry (theme Reconstructive & Regenerative Medicine), celebrated his 25th work anniversary at Radboudumc.

read more

Tjitske Kleefstra appointed endowed professor of Clinical genetics and psychopathology of rare syndromes

17 September 2020

Tjitske Kleefstra has been appointed endowed professor of Clinical genetics and psychopathology of rare syndromes at the department of Neurodevelopmental disorders, with effect from 1 September.

read more

Annette Schenck appointed professor of Translational Genetics

17 September 2020

Annette Schenck has been appointed professor of Translational Genetics at the department of Neurodevelopmental disorders, with effect from 1 August. The chair will bring together fundamental and translational research in the field of brain developmental disorders.

read more

Centuries-old medicine reduces the risk of new cardiovascular disease in heart patients

17 September 2020

Colchicine, an anti-inflammatory drug that has been used for gout for centuries, has been shown to prevent cardiovascular disease in patients who have had a heart attack or are suffering from narrowed coronary arteries. Results of the study are published in the New England Journal of Medicine.

read more

Radboudumc does large-scale research on systemic sclerosis

10 September 2020

In rare diseases, such as systemic sclerosis, it’s often difficult to conduct large-scale research. Rheumatologist Madelon Vonk has managed to follow enough patients with systemic sclerosis for years. The results of her research have been published in BMJ Annal of the Rheumatic Diseases.

read more